SANTA CLARA, Calif.--(BUSINESS WIRE)--XenoPort, Inc. (Nasdaq:XNPT) announced today the appointment of Dennis M. Fenton, Ph.D., to its board of directors. Dr. Fenton has over 30 years of pharmaceutical and biotechnology experience, including over 25 years at Amgen Inc., a biotechnology company.
